Syndax Pharmaceuticals
SNDX
SNDX
130 hedge funds and large institutions have $1.08B invested in Syndax Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 55 increasing their positions, 43 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
130
Holders Change
-12
Holders Change %
-8.45%
% of All Funds
2.29%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.05%
New
13
Increased
55
Reduced
43
Closed
25
Calls
$5.55M
Puts
$3.82M
Net Calls
+$1.74M
Net Calls Change
-$3.28M
Top Buyers
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$0 |
| 2 |
2
Millennium Management
New York
|
$0 |
| 3 |
BI
3
BVF Inc
San Francisco,
California
|
$3.66M |
| 4 |
VA
4
VR Adviser
New York
|
$13.2M |
| 5 |
5
Two Sigma Investments
New York
|
$5.4M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GTCM
151
Gyon Technologies Capital Management
Denville,
New Jersey
| – | -$211K | -9,478 | Closed |
|
|
GAM
152
Gotham Asset Management
New York
| – | -$749K | -7,413 | Closed |
|
|
NWA
153
Navis Wealth Advisors
Rye Brook,
New York
| – | -$133K | -6,000 | Closed |
|
154
Simplex Trading
Chicago,
Illinois
| – | -$30K | -1,352 | Closed |
|
|
IA
155
IFP Advisors
Tampa,
Florida
| – | -$1K | -31 | Closed |
|